| 000 | 01150 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515071900.0 | ||
| 264 | 0 | _c20090612 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a0028-3886 | ||
| 024 | 7 |
_a10.4103/0028-3886.32797 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKumar, Sudhir | |
| 245 | 0 | 0 |
_aThrombolysis with tissue plasminogen activator: protocol violation is not an option. _h[electronic resource] |
| 260 |
_bNeurology India _c |
||
| 300 |
_a174; author reply 174-5 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Ischemia _xcomplications |
| 650 | 0 | 4 |
_aCerebral Hemorrhage _xcomplications |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlasminogen Activators _xtherapeutic use |
| 650 | 0 | 4 | _aReperfusion |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 773 | 0 |
_tNeurology India _gvol. 55 _gno. 2 _gp. 174; author reply 174-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4103/0028-3886.32797 _zAvailable from publisher's website |
| 999 |
_c17096835 _d17096835 |
||